Trials / Sponsors / Idience Co., Ltd.
Idience Co., Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Food Effect Study of IDX-1197 in Healthy Subjects Healthy Male | Phase 1 | 2022-01-16 |
| Active Not Recruiting | Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Gastric Cancer | Phase 1 / Phase 2 | 2021-06-28 |
| Completed | Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency | Phase 1 / Phase 2 | 2019-11-06 |
| Completed | Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2017-08-29 |